180
Participants
Start Date
April 8, 2017
Primary Completion Date
June 30, 2026
Study Completion Date
June 30, 2026
Cannabidiol as add-on
Cannabidiol capsules 2x200 mg twice a day as add-on to individualized pharmacological treatment with either amisulpride, aripiprazole, olanzapine, quetiapine or risperidone over 26 weeks
Placebo as add-on
Placebo capsules 2x200 mg twice a day as add-on to individualized pharmacological treatment with either amisulpride, aripiprazole, olanzapine, quetiapine or risperidone over 26 weeks
RECRUITING
Dept. of Psychiatry and Psychotherapy, Charité, Campus Charité-Mitte, Berlin
RECRUITING
Department of Psychiatry und Psychotherapy, University Hospital Hamburg-Eppendorf, Hamburg
RECRUITING
Dept. of Psychiatry and Psychotherapy, University Hospital of Cologne, Cologne
RECRUITING
Department of Psychiatry, Psychotherapy, and Psychosomatics, RWTH Aachen, Aachen
RECRUITING
Dep. of Psychiatry and Psychotherapy, Central Institute of Mental Health, Mannheim
NOT_YET_RECRUITING
Dept. of Psychiatry and Psychotherapy, Ludwig-Maximillians-University Munich, Munich
Central Institute of Mental Health, Mannheim
OTHER